APA

Mischoulon D., Hylek L., Yeung A. S., Clain A. J., Baer L., Cusin C., Ionescu D. F., Alpert J. E., Soskin D. P. & Fava M. (022018). Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. : Journal of affective disorders.

Chicago

Mischoulon D, Hylek L, Yeung A S, Clain A J, Baer L, Cusin C, Ionescu D F, Alpert J E, Soskin D P and Fava M. 022018. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. : Journal of affective disorders.

Harvard

Mischoulon D., Hylek L., Yeung A. S., Clain A. J., Baer L., Cusin C., Ionescu D. F., Alpert J. E., Soskin D. P. and Fava M. (022018). Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. : Journal of affective disorders.

MLA

Mischoulon D, Hylek L, Yeung A S, Clain A J, Baer L, Cusin C, Ionescu D F, Alpert J E, Soskin D P and Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. : Journal of affective disorders. 022018.